These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 11325833)

  • 1. Transcriptional activation of the thyroglobulin promoter directing suicide gene expression by thyroid transcription factor-1 in thyroid cancer cells.
    Shimura H; Suzuki H; Miyazaki A; Furuya F; Ohta K; Haraguchi K; Endo T; Onaya T
    Cancer Res; 2001 May; 61(9):3640-6. PubMed ID: 11325833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A tandemly repeated thyroglobulin core promoter has potential to enhance efficacy for tissue-specific gene therapy for thyroid carcinomas.
    Takeda T; Yamazaki M; Minemura K; Imai Y; Inaba H; Suzuki S; Miyamoto T; Ichikawa K; Kakizawa T; Mori J; DeGroot LJ; Hashizume K
    Cancer Gene Ther; 2002 Oct; 9(10):864-74. PubMed ID: 12224028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of malignant gliomas with a replicating adenoviral vector expressing herpes simplex virus-thymidine kinase.
    Nanda D; Vogels R; Havenga M; Avezaat CJ; Bout A; Smitt PS
    Cancer Res; 2001 Dec; 61(24):8743-50. PubMed ID: 11751394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced efficacy of transcriptionally targeted suicide gene/prodrug therapy for thyroid carcinoma with the Cre-loxP system.
    Nagayama Y; Nishihara E; Iitaka M; Namba H; Yamashita S; Niwa M
    Cancer Res; 1999 Jul; 59(13):3049-52. PubMed ID: 10397242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adenoviral-mediated gene therapy for thyroid carcinoma using thymidine kinase controlled by thyroglobulin promoter demonstrates high specificity and low toxicity.
    Zhang R; Straus FH; DeGroot LJ
    Thyroid; 2001 Feb; 11(2):115-23. PubMed ID: 11288980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcriptional targeting of virus-mediated gene transfer by the human hexokinase II promoter.
    Määttä AM; Korja S; Venhoranta H; Hakkarainen T; Pirinen E; Heikkinen S; Pellinen R; Mäkinen K; Wahlfors J
    Int J Mol Med; 2006 Nov; 18(5):901-8. PubMed ID: 17016620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene therapy for prostate cancer: toxicological profile of four HSV-tk transducing adenoviral vectors regulated by different promoters.
    Ebara S; Shimura S; Nasu Y; Kaku H; Kumon H; Yang G; Wang J; Timme TL; Aguilar-Cordova E; Thompson TC
    Prostate Cancer Prostatic Dis; 2002; 5(4):316-25. PubMed ID: 12627218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of TTF-1 and PAX-8 restores thyroglobulin gene promoter activity in ARO and WRO cell lines.
    Chun YS; Saji M; Zeiger MA
    Surgery; 1998 Dec; 124(6):1100-5. PubMed ID: 9854590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In situ generation of pseudotyped retroviral progeny by adenovirus-mediated transduction of tumor cells enhances the killing effect of HSV-tk suicide gene therapy in vitro and in vivo.
    Okada T; Caplen NJ; Ramsey WJ; Onodera M; Shimazaki K; Nomoto T; Ajalli R; Wildner O; Morris J; Kume A; Hamada H; Blaese RM; Ozawa K
    J Gene Med; 2004 Mar; 6(3):288-99. PubMed ID: 15026990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Construction and identification of recombinant vectors carrying herpes simplex virus thymidine kinase genes expressed in vascular endothelial cells].
    Liu XP; Li BJ; Zhang C
    Ai Zheng; 2006 Feb; 25(2):179-84. PubMed ID: 16480582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adenovirus-mediated transfer of thyroid transcription factor-1 induces radioiodide organification and retention in thyroid cancer cells.
    Furuya F; Shimura H; Miyazaki A; Taki K; Ohta K; Haraguchi K; Onaya T; Endo T; Kobayashi T
    Endocrinology; 2004 Nov; 145(11):5397-405. PubMed ID: 15271884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Construction of a plasmid vector of fused protein genes driven by human insulin-like growth factor II P3 promoter].
    Zhou HK; Yang DH; Tang SH; Huang W; Lu XH
    Zhonghua Yi Xue Za Zhi; 2006 Jan; 86(2):106-10. PubMed ID: 16620715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Adenovirus-mediated double suicide gene selectively kills breast cancer MCF-7 cells in vitro].
    Kong H; Huang ZH; Li Q; Yang LC; Yu JL; Li Z
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jun; 28(6):907-10. PubMed ID: 18583225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene therapy targeting for hepatocellular carcinoma: selective and enhanced suicide gene expression regulated by a hypoxia-inducible enhancer linked to a human alpha-fetoprotein promoter.
    Ido A; Uto H; Moriuchi A; Nagata K; Onaga Y; Onaga M; Hori T; Hirono S; Hayashi K; Tamaoki T; Tsubouchi H
    Cancer Res; 2001 Apr; 61(7):3016-21. PubMed ID: 11306481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The telomerase reverse transcriptase promoter drives efficacious tumor suicide gene therapy while preventing hepatotoxicity encountered with constitutive promoters.
    Majumdar AS; Hughes DE; Lichtsteiner SP; Wang Z; Lebkowski JS; Vasserot AP
    Gene Ther; 2001 Apr; 8(7):568-78. PubMed ID: 11319624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The adenovirus-mediated HSV-TK/GCV suicide gene system in the treatment of tongue carcinoma cell line].
    Huang H; Wang A
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2001 Nov; 36(6):457-60. PubMed ID: 11930726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenovirus-mediated tumor-specific combined gene therapy using Herpes simplex virus thymidine/ganciclovir system and murine interleukin-12 induces effective antitumor activity against medullary thyroid carcinoma.
    Yamazaki M; Straus FH; Messina M; Robinson BG; Takeda T; Hashizume K; DeGroot LJ
    Cancer Gene Ther; 2004 Jan; 11(1):8-15. PubMed ID: 14681722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A germline mutation (A339V) in thyroid transcription factor-1 (TITF-1/NKX2.1) in patients with multinodular goiter and papillary thyroid carcinoma.
    Ngan ES; Lang BH; Liu T; Shum CK; So MT; Lau DK; Leon TY; Cherny SS; Tsai SY; Lo CY; Khoo US; Tam PK; Garcia-Barceló MM
    J Natl Cancer Inst; 2009 Feb; 101(3):162-75. PubMed ID: 19176457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene therapy for hepatoma cells using a retrovirus vector carrying herpes simplex virus thymidine kinase gene under the control of human alpha-fetoprotein gene promoter.
    Ido A; Nakata K; Kato Y; Nakao K; Murata K; Fujita M; Ishii N; Tamaoki T; Shiku H; Nagataki S
    Cancer Res; 1995 Jul; 55(14):3105-9. PubMed ID: 7541712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A minimum c-erbB-2 promoter-mediated expression of herpes simplex virus thymidine kinase gene confers selective cytotoxicity of human breast cancer cells to ganciclovir.
    Maeda T; O-Wang J; Matsubara H; Asano T; Ochiai T; Sakiyama S; Tagawa M
    Cancer Gene Ther; 2001 Nov; 8(11):890-6. PubMed ID: 11773979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.